Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jan;89(1):105284.
doi: 10.1016/j.jbspin.2021.105284. Epub 2021 Oct 1.

Answer to Cadiou et al. "SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger?". Joint Bone Spine 2021;88:105282

Ciro Manzo  1 , Alberto Castagna  2 , Maria Natale  3 , Giovanni Ruotolo  4
Affiliations
Comment

Answer to Cadiou et al. "SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger?". Joint Bone Spine 2021;88:105282

Ciro Manzo et al. Joint Bone Spine. 2022 Jan.
No abstract available

Keywords: COVID-19 vaccines; Polymyalgia rheumatica.

PubMed Disclaimer

Comment on

References

    1. Cadiou S., Perdriger A., Ardois S., et al. SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID19 vaccine shot as a trigger? Joint Bone Spine. 2021;88:105282. - PMC - PubMed
    1. Manzo C., Castagna A., Ruotolo G. Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica? Joint Bone Spine. 2021;88:105150. - PMC - PubMed
    1. Manzo C., Natale M., Castagna A. Polymyalgia rheumatica as uncommon adverse event following immunization with COVID-19 vaccine: a case report and review of literature. Aging Med. 2021;00:1–5. doi: 10.1002/agm2.12171. [Online ahead of print] - DOI - PMC - PubMed
    1. Dejaco C., Singh Y.P., Perel P., et al. 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2015;74:1799–1807. - PubMed
    1. Watad A., De Marco G., Mahajna H., et al. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines. 2021;9:435. - PMC - PubMed

Substances